APA

Ren X., Li J., Xu X., Wang C. & Cheng Y. (20170613). IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys. : Experimental eye research.

Chicago

Ren Xinyi, Li Jia, Xu Xianxing, Wang Chunming and Cheng Yuanguo. 20170613. IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys. : Experimental eye research.

Harvard

Ren X., Li J., Xu X., Wang C. and Cheng Y. (20170613). IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys. : Experimental eye research.

MLA

Ren Xinyi, Li Jia, Xu Xianxing, Wang Chunming and Cheng Yuanguo. IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys. : Experimental eye research. 20170613.